Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Murate

Showing results (81-90 of 119) with videos related to

Pageof 12
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1993
Phase II study of carboplatin, cisplatin, and vindesine in advanced non-small-cell lung cancerH Saito, K Shimokata, H Saka, et al.
Internal Medicine (Tokyo, Japan)|February 1, 1992
Chest roentgenogram classification and clinical parameters in patients with active pulmonary tuberculosisT Murate, K Shimokata, A Watanabe, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 11, 2008
Skewed X chromosome inactivation in fraternal female twins results in moderately severe and mild haemophilia BK Okumura, Y Fujimori, A Takagi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 1, 1989
[Salvage chemotherapy with a combination of VP-16, ifosfamide, procarbazine, prednisolone, bleomycin and methotrexate (VIPP-BM) for refractory malignant lymphoma]K Ohnishi, T Hotta, T Murate, et al.
British Journal of Haematology|August 1, 1997
Complementarity determining region-III is a useful molecular marker for the evaluation of minimal residual disease in mantle cell lymphomaT Kurokawa, T Kinoshita, T Murate, et al.
The Japanese Journal of Antibiotics|December 1, 1990
[Clinical evaluation of cefbuperazone in severe infections complicated with hematological disorders]H Mizuno, H Yamao, H Saito, et al.
Leukemia|February 1, 1995
Establishment and characterization of an immature human megakaryoblastic cell line, MEG-A2A Abe, N Emi, H Kato, et al.
Leukemia|November 1, 1995
Establishment and characterization of a novel cell line, TK-6, derived from T cell blast crisis of chronic myelogenous leukemia, with the secretion of parathyroid hormone-related proteinT Watanabe, T Kataoka, S Mizuta, et al.
The Japanese Journal of Antibiotics|November 1, 1981
[Clinical evaluation of amikacin in severe infections with hematological malignant diseases (author's transl)]T Hotta, N Hirabayashi, K Shimizu, et al.
Experimental Cell Research|September 1, 1993
The close relationship between DNA replication and the selection of differentiation lineages of human erythroleukemia cell lines K562, HEL, and TF1 into either erythroid or megakaryocytic lineagesT Murate, S Saga, T Hotta, et al.
Pageof 12

Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
Cancer Chemotherapy and Pharmacology|January 1, 1993
Phase II study of carboplatin, cisplatin, and vindesine in advanced non-small-cell lung cancerH Saito, K Shimokata, H Saka, et al.
Internal Medicine (Tokyo, Japan)|February 1, 1992
Chest roentgenogram classification and clinical parameters in patients with active pulmonary tuberculosisT Murate, K Shimokata, A Watanabe, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 11, 2008
Skewed X chromosome inactivation in fraternal female twins results in moderately severe and mild haemophilia BK Okumura, Y Fujimori, A Takagi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 1, 1989
[Salvage chemotherapy with a combination of VP-16, ifosfamide, procarbazine, prednisolone, bleomycin and methotrexate (VIPP-BM) for refractory malignant lymphoma]K Ohnishi, T Hotta, T Murate, et al.
British Journal of Haematology|August 1, 1997
Complementarity determining region-III is a useful molecular marker for the evaluation of minimal residual disease in mantle cell lymphomaT Kurokawa, T Kinoshita, T Murate, et al.
The Japanese Journal of Antibiotics|December 1, 1990
[Clinical evaluation of cefbuperazone in severe infections complicated with hematological disorders]H Mizuno, H Yamao, H Saito, et al.
Leukemia|February 1, 1995
Establishment and characterization of an immature human megakaryoblastic cell line, MEG-A2A Abe, N Emi, H Kato, et al.
Leukemia|November 1, 1995
Establishment and characterization of a novel cell line, TK-6, derived from T cell blast crisis of chronic myelogenous leukemia, with the secretion of parathyroid hormone-related proteinT Watanabe, T Kataoka, S Mizuta, et al.
The Japanese Journal of Antibiotics|November 1, 1981
[Clinical evaluation of amikacin in severe infections with hematological malignant diseases (author's transl)]T Hotta, N Hirabayashi, K Shimizu, et al.
Experimental Cell Research|September 1, 1993
The close relationship between DNA replication and the selection of differentiation lineages of human erythroleukemia cell lines K562, HEL, and TF1 into either erythroid or megakaryocytic lineagesT Murate, S Saga, T Hotta, et al.
Pageof 12